摘要
目的:探究微创穿刺引流术治疗颅内血肿患者临床疗效。方法:选取2014年1月至2014年10月我院收治的颅内血肿患者100例,给予微创穿刺引流术治疗。治疗结束后,随访一年,记录观察100例颅脑损伤患者ADL评分、并发症、血肿清除率、存活率以及死亡率。结果:1治疗后一年内,患者ADL评分,I级43例,Ⅱ级31例,Ⅲ级14例,Ⅳ级4例,Ⅴ级3例;2手术一周后,患者血肿清除率≥90%者91例,60%≤血肿清除率<90%者7例,血肿清除率<60%者2例;3100例患者中并发肺炎6例,并发脑梗死4例,并发应激性溃疡5例;4手术后一年内,死亡患者5例,生存患者95例。结论:微创穿刺引流术能有效降低颅内血肿患者并发症的形成,恢复神经缺损功能,降低死亡率,提高生存率。在临床用以治疗颅内血肿患者具有较好的前景。
ABSTRACT Objective: To study the effect of the minimally invasive puncture drainage on patients with intracranial hematoma. Methods: 100 patients with intracranial hematoma were selected, and treated with minimally invasive puncture drainage and followed up for a year. The ADL score, postoperative complications, hematoma clearance rate, survival rate and mortality was recorded. Results:① One year after treatment, for the ADL score of patients, there were 43 cases of grade Ⅰ, 31 cases of grade Ⅱ, Ⅲ 14 cases, 4 cases of grade Ⅳ, 3 cases of grade V;②One week after operation, the hematoma clearance rate in 91 patients was more than 90%, and 7 cases of hematoma clearance rate was between 60% and 90%, and 2 cases of hematoma clearance rate was below 60%; ③for the postoperative complications, there was 6 patients with pneumonia in 100 patients, 4 cases with cerebral infarction, 5 cases with stress ulcer; ④Within one year after operation, 5 patients died and 95 patients survived. Conclusions: Minimally invasive surgery can effectively reduce the complications of patientswith intracranial hematoma, and recover the neural fimction, decrease the mortality and improve the survival rate, worthy of clinical application and promotion.
出处
《现代生物医学进展》
CAS
2016年第16期3052-3054,3069,共4页
Progress in Modern Biomedicine
基金
国家自然科学基金青年科学基金项目(31200800)
关键词
微创穿刺引流术
颅内血肿
神经功能
Minimally invasive puncture drainage
Intracranial hematoma
Nerve function